Skip to main content
PMC home page
Molecular and Cellular Biology logoLink to Molecular and Cellular Biology
. 1995 Nov;15(11):5879–5887. doi: 10.1128/mcb.15.11.5879

Endocytosis and vacuolar degradation of the plasma membrane-localized Pdr5 ATP-binding cassette multidrug transporter in Saccharomyces cerevisiae.

R Egner 1, Y Mahé 1, R Pandjaitan 1, K Kuchler 1
PMCID: PMC230839  PMID: 7565740

Abstract

Multidrug resistance (MDR) to different cytotoxic compounds in the yeast Saccharomyces cerevisiae can arise from overexpression of the Pdr5 (Sts1, Ydr1, or Lem1) ATP-binding cassette (ABC) multidrug transporter. We have raised polyclonal antibodies recognizing the yeast Pdr5 ABC transporter to study its biogenesis and to analyze the molecular mechanisms underlying MDR development. Subcellular fractionation and indirect immunofluorescence experiments showed that Pdr5 is localized in the plasma membrane. In addition, pulse-chase radiolabeling of cells and immunoprecipitation indicated that Pdr5 is a short-lived membrane protein with a half-life of about 60 to 90 min. A dramatic metabolic stabilization of Pdr5 was observed in delta pep4 mutant cells defective in vacuolar proteinases, and indirect immunofluorescence showed that Pdr5 accumulates in vacuoles of stationary-phase delta pep4 mutant cells, demonstrating that Pdr5 turnover requires vacuolar proteolysis. However, Pdr5 turnover does not require a functional proteasome, since the half-life of Pdr5 was unaffected in either pre1-1 or pre1-1 pre2-1 mutants defective in the multicatalytic cytoplasmic proteasome that is essential for cytoplasmic protein degradation. Immunofluorescence analysis revealed that vacuolar delivery of Pdr5 is blocked in conditional end4 endocytosis mutants at the restrictive temperature, showing that endocytosis delivers Pdr5 from the plasma membrane to the vacuole.

Full Text

The Full Text of this article is available as a PDF (916.6 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Antebi A., Fink G. R. The yeast Ca(2+)-ATPase homologue, PMR1, is required for normal Golgi function and localizes in a novel Golgi-like distribution. Mol Biol Cell. 1992 Jun;3(6):633–654. doi: 10.1091/mbc.3.6.633. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Balzi E., Chen W., Ulaszewski S., Capieaux E., Goffeau A. The multidrug resistance gene PDR1 from Saccharomyces cerevisiae. J Biol Chem. 1987 Dec 15;262(35):16871–16879. [PubMed] [Google Scholar]
  3. Balzi E., Goffeau A. Genetics and biochemistry of yeast multidrug resistance. Biochim Biophys Acta. 1994 Aug 30;1187(2):152–162. doi: 10.1016/0005-2728(94)90102-3. [DOI] [PubMed] [Google Scholar]
  4. Balzi E., Wang M., Leterme S., Van Dyck L., Goffeau A. PDR5, a novel yeast multidrug resistance conferring transporter controlled by the transcription regulator PDR1. J Biol Chem. 1994 Jan 21;269(3):2206–2214. [PubMed] [Google Scholar]
  5. Benito B., Moreno E., Lagunas R. Half-life of the plasma membrane ATPase and its activating system in resting yeast cells. Biochim Biophys Acta. 1991 Apr 2;1063(2):265–268. doi: 10.1016/0005-2736(91)90381-h. [DOI] [PubMed] [Google Scholar]
  6. Berkower C., Loayza D., Michaelis S. Metabolic instability and constitutive endocytosis of STE6, the a-factor transporter of Saccharomyces cerevisiae. Mol Biol Cell. 1994 Nov;5(11):1185–1198. doi: 10.1091/mbc.5.11.1185. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Bissinger P. H., Kuchler K. Molecular cloning and expression of the Saccharomyces cerevisiae STS1 gene product. A yeast ABC transporter conferring mycotoxin resistance. J Biol Chem. 1994 Feb 11;269(6):4180–4186. [PubMed] [Google Scholar]
  8. Borst P., Schinkel A. H., Smit J. J., Wagenaar E., Van Deemter L., Smith A. J., Eijdems E. W., Baas F., Zaman G. J. Classical and novel forms of multidrug resistance and the physiological functions of P-glycoproteins in mammals. Pharmacol Ther. 1993 Nov;60(2):289–299. doi: 10.1016/0163-7258(93)90011-2. [DOI] [PubMed] [Google Scholar]
  9. Brown V. I., Greene M. I. Molecular and cellular mechanisms of receptor-mediated endocytosis. DNA Cell Biol. 1991 Jul-Aug;10(6):399–409. doi: 10.1089/dna.1991.10.399. [DOI] [PubMed] [Google Scholar]
  10. Cole S. P., Bhardwaj G., Gerlach J. H., Mackie J. E., Grant C. E., Almquist K. C., Stewart A. J., Kurz E. U., Duncan A. M., Deeley R. G. Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line. Science. 1992 Dec 4;258(5088):1650–1654. doi: 10.1126/science.1360704. [DOI] [PubMed] [Google Scholar]
  11. Davis N. G., Horecka J. L., Sprague G. F., Jr Cis- and trans-acting functions required for endocytosis of the yeast pheromone receptors. J Cell Biol. 1993 Jul;122(1):53–65. doi: 10.1083/jcb.122.1.53. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Decottignies A., Kolaczkowski M., Balzi E., Goffeau A. Solubilization and characterization of the overexpressed PDR5 multidrug resistance nucleotide triphosphatase of yeast. J Biol Chem. 1994 Apr 29;269(17):12797–12803. [PubMed] [Google Scholar]
  13. Delahodde A., Delaveau T., Jacq C. Positive autoregulation of the yeast transcription factor Pdr3p, which is involved in control of drug resistance. Mol Cell Biol. 1995 Aug;15(8):4043–4051. doi: 10.1128/mcb.15.8.4043. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Dexter D., Moye-Rowley W. S., Wu A. L., Golin J. Mutations in the yeast PDR3, PDR4, PDR7 and PDR9 pleiotropic (multiple) drug resistance loci affect the transcript level of an ATP binding cassette transporter encoding gene, PDR5. Genetics. 1994 Feb;136(2):505–515. doi: 10.1093/genetics/136.2.505. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Galan J. M., Volland C., Urban-Grimal D., Haguenauer-Tsapis R. The yeast plasma membrane uracil permease is stabilized against stress induced degradation by a point mutation in a cyclin-like "destruction box". Biochem Biophys Res Commun. 1994 Jun 15;201(2):769–775. doi: 10.1006/bbrc.1994.1767. [DOI] [PubMed] [Google Scholar]
  16. Gottesman M. M., Pastan I. Biochemistry of multidrug resistance mediated by the multidrug transporter. Annu Rev Biochem. 1993;62:385–427. doi: 10.1146/annurev.bi.62.070193.002125. [DOI] [PubMed] [Google Scholar]
  17. Heinemeyer W., Gruhler A., Möhrle V., Mahé Y., Wolf D. H. PRE2, highly homologous to the human major histocompatibility complex-linked RING10 gene, codes for a yeast proteasome subunit necessary for chrymotryptic activity and degradation of ubiquitinated proteins. J Biol Chem. 1993 Mar 5;268(7):5115–5120. [PubMed] [Google Scholar]
  18. Heinemeyer W., Tröndle N., Albrecht G., Wolf D. H. PRE5 and PRE6, the last missing genes encoding 20S proteasome subunits from yeast? Indication for a set of 14 different subunits in the eukaryotic proteasome core. Biochemistry. 1994 Oct 11;33(40):12229–12237. doi: 10.1021/bi00206a028. [DOI] [PubMed] [Google Scholar]
  19. Hertle K., Haase E., Brendel M. The SNQ3 gene of Saccharomyces cerevisiae confers hyper-resistance to several functionally unrelated chemicals. Curr Genet. 1991 Jun;19(6):429–433. doi: 10.1007/BF00312733. [DOI] [PubMed] [Google Scholar]
  20. Higgins C. F. ABC transporters: from microorganisms to man. Annu Rev Cell Biol. 1992;8:67–113. doi: 10.1146/annurev.cb.08.110192.000435. [DOI] [PubMed] [Google Scholar]
  21. Hirata D., Yano K., Miyahara K., Miyakawa T. Saccharomyces cerevisiae YDR1, which encodes a member of the ATP-binding cassette (ABC) superfamily, is required for multidrug resistance. Curr Genet. 1994 Oct;26(4):285–294. doi: 10.1007/BF00310491. [DOI] [PubMed] [Google Scholar]
  22. Katzmann D. J., Burnett P. E., Golin J., Mahé Y., Moye-Rowley W. S. Transcriptional control of the yeast PDR5 gene by the PDR3 gene product. Mol Cell Biol. 1994 Jul;14(7):4653–4661. doi: 10.1128/mcb.14.7.4653. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Knop M., Schiffer H. H., Rupp S., Wolf D. H. Vacuolar/lysosomal proteolysis: proteases, substrates, mechanisms. Curr Opin Cell Biol. 1993 Dec;5(6):990–996. doi: 10.1016/0955-0674(93)90082-2. [DOI] [PubMed] [Google Scholar]
  24. Kralli A., Bohen S. P., Yamamoto K. R. LEM1, an ATP-binding-cassette transporter, selectively modulates the biological potency of steroid hormones. Proc Natl Acad Sci U S A. 1995 May 9;92(10):4701–4705. doi: 10.1073/pnas.92.10.4701. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Kuchler K., Dohlman H. G., Thorner J. The a-factor transporter (STE6 gene product) and cell polarity in the yeast Saccharomyces cerevisiae. J Cell Biol. 1993 Mar;120(5):1203–1215. doi: 10.1083/jcb.120.5.1203. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Kuchler K., Sterne R. E., Thorner J. Saccharomyces cerevisiae STE6 gene product: a novel pathway for protein export in eukaryotic cells. EMBO J. 1989 Dec 20;8(13):3973–3984. doi: 10.1002/j.1460-2075.1989.tb08580.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Kuchler K., Thorner J. Secretion of peptides and proteins lacking hydrophobic signal sequences: the role of adenosine triphosphate-driven membrane translocators. Endocr Rev. 1992 Aug;13(3):499–514. doi: 10.1210/edrv-13-3-499. [DOI] [PubMed] [Google Scholar]
  28. Kölling R., Hollenberg C. P. The ABC-transporter Ste6 accumulates in the plasma membrane in a ubiquitinated form in endocytosis mutants. EMBO J. 1994 Jul 15;13(14):3261–3271. doi: 10.1002/j.1460-2075.1994.tb06627.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Leppert G., McDevitt R., Falco S. C., Van Dyk T. K., Ficke M. B., Golin J. Cloning by gene amplification of two loci conferring multiple drug resistance in Saccharomyces. Genetics. 1990 May;125(1):13–20. doi: 10.1093/genetics/125.1.13. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. McGrath J. P., Varshavsky A. The yeast STE6 gene encodes a homologue of the mammalian multidrug resistance P-glycoprotein. Nature. 1989 Aug 3;340(6232):400–404. doi: 10.1038/340400a0. [DOI] [PubMed] [Google Scholar]
  31. Meyers S., Schauer W., Balzi E., Wagner M., Goffeau A., Golin J. Interaction of the yeast pleiotropic drug resistance genes PDR1 and PDR5. Curr Genet. 1992 May;21(6):431–436. doi: 10.1007/BF00351651. [DOI] [PubMed] [Google Scholar]
  32. Moye-Rowley W. S., Harshman K. D., Parker C. S. Yeast YAP1 encodes a novel form of the jun family of transcriptional activator proteins. Genes Dev. 1989 Mar;3(3):283–292. doi: 10.1101/gad.3.3.283. [DOI] [PubMed] [Google Scholar]
  33. Nakamoto R. K., Rao R., Slayman C. W. Expression of the yeast plasma membrane [H+]ATPase in secretory vesicles. A new strategy for directed mutagenesis. J Biol Chem. 1991 Apr 25;266(12):7940–7949. [PubMed] [Google Scholar]
  34. Peters J. M. Proteasomes: protein degradation machines of the cell. Trends Biochem Sci. 1994 Sep;19(9):377–382. doi: 10.1016/0968-0004(94)90115-5. [DOI] [PubMed] [Google Scholar]
  35. Pringle J. R., Adams A. E., Drubin D. G., Haarer B. K. Immunofluorescence methods for yeast. Methods Enzymol. 1991;194:565–602. doi: 10.1016/0076-6879(91)94043-c. [DOI] [PubMed] [Google Scholar]
  36. Raths S., Rohrer J., Crausaz F., Riezman H. end3 and end4: two mutants defective in receptor-mediated and fluid-phase endocytosis in Saccharomyces cerevisiae. J Cell Biol. 1993 Jan;120(1):55–65. doi: 10.1083/jcb.120.1.55. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Richter-Ruoff B., Wolf D. H., Hochstrasser M. Degradation of the yeast MAT alpha 2 transcriptional regulator is mediated by the proteasome. FEBS Lett. 1994 Oct 31;354(1):50–52. doi: 10.1016/0014-5793(94)01085-4. [DOI] [PubMed] [Google Scholar]
  38. Riezman H. Yeast endocytosis. Trends Cell Biol. 1993 Aug;3(8):273–277. doi: 10.1016/0962-8924(93)90056-7. [DOI] [PubMed] [Google Scholar]
  39. Rohrer J., Bénédetti H., Zanolari B., Riezman H. Identification of a novel sequence mediating regulated endocytosis of the G protein-coupled alpha-pheromone receptor in yeast. Mol Biol Cell. 1993 May;4(5):511–521. doi: 10.1091/mbc.4.5.511. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Sathe G. M., O'Brien S., McLaughlin M. M., Watson F., Livi G. P. Use of polymerase chain reaction for rapid detection of gene insertions in whole yeast cells. Nucleic Acids Res. 1991 Sep 11;19(17):4775–4775. doi: 10.1093/nar/19.17.4775. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Schekman R. Genetic and biochemical analysis of vesicular traffic in yeast. Curr Opin Cell Biol. 1992 Aug;4(4):587–592. doi: 10.1016/0955-0674(92)90076-o. [DOI] [PubMed] [Google Scholar]
  42. Schork S. M., Bee G., Thumm M., Wolf D. H. Catabolite inactivation of fructose-1,6-bisphosphatase in yeast is mediated by the proteasome. FEBS Lett. 1994 Aug 1;349(2):270–274. doi: 10.1016/0014-5793(94)00668-7. [DOI] [PubMed] [Google Scholar]
  43. Servos J., Haase E., Brendel M. Gene SNQ2 of Saccharomyces cerevisiae, which confers resistance to 4-nitroquinoline-N-oxide and other chemicals, encodes a 169 kDa protein homologous to ATP-dependent permeases. Mol Gen Genet. 1993 Jan;236(2-3):214–218. doi: 10.1007/BF00277115. [DOI] [PubMed] [Google Scholar]
  44. Singer-Krüger B., Frank R., Crausaz F., Riezman H. Partial purification and characterization of early and late endosomes from yeast. Identification of four novel proteins. J Biol Chem. 1993 Jul 5;268(19):14376–14386. [PubMed] [Google Scholar]
  45. Teichert U., Mechler B., Müller H., Wolf D. H. Lysosomal (vacuolar) proteinases of yeast are essential catalysts for protein degradation, differentiation, and cell survival. J Biol Chem. 1989 Sep 25;264(27):16037–16045. [PubMed] [Google Scholar]
  46. Volland C., Urban-Grimal D., Géraud G., Haguenauer-Tsapis R. Endocytosis and degradation of the yeast uracil permease under adverse conditions. J Biol Chem. 1994 Apr 1;269(13):9833–9841. [PubMed] [Google Scholar]
  47. Walworth N. C., Novick P. J. Purification and characterization of constitutive secretory vesicles from yeast. J Cell Biol. 1987 Jul;105(1):163–174. doi: 10.1083/jcb.105.1.163. [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. Woolford C. A., Noble J. A., Garman J. D., Tam M. F., Innis M. A., Jones E. W. Phenotypic analysis of proteinase A mutants. Implications for autoactivation and the maturation pathway of the vacuolar hydrolases of Saccharomyces cerevisiae. J Biol Chem. 1993 Apr 25;268(12):8990–8998. [PubMed] [Google Scholar]
  49. Yaglom J., Linskens M. H., Sadis S., Rubin D. M., Futcher B., Finley D. p34Cdc28-mediated control of Cln3 cyclin degradation. Mol Cell Biol. 1995 Feb;15(2):731–741. doi: 10.1128/mcb.15.2.731. [DOI] [PMC free article] [PubMed] [Google Scholar]
  50. Zaman G. J., Flens M. J., van Leusden M. R., de Haas M., Mülder H. S., Lankelma J., Pinedo H. M., Scheper R. J., Baas F., Broxterman H. J. The human multidrug resistance-associated protein MRP is a plasma membrane drug-efflux pump. Proc Natl Acad Sci U S A. 1994 Sep 13;91(19):8822–8826. doi: 10.1073/pnas.91.19.8822. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Molecular and Cellular Biology are provided here courtesy of Taylor & Francis

RESOURCES